INKON Life Technology Co., Ltd. (SHE:300143)
10.49
-0.18 (-1.69%)
At close: Nov 4, 2025
INKON Life Technology Revenue
INKON Life Technology had revenue of 514.81M CNY in the quarter ending September 30, 2025, with 27.27% growth. This brings the company's revenue in the last twelve months to 1.69B, up 5.91% year-over-year. In the year 2024, INKON Life Technology had annual revenue of 1.56B with 6.01% growth.
Revenue (ttm)
1.69B
Revenue Growth
+5.91%
P/S Ratio
4.62
Revenue / Employee
765.42K
Employees
2,207
Market Cap
7.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.56B | 88.44M | 6.01% |
| Dec 31, 2023 | 1.47B | 314.55M | 27.20% |
| Jan 1, 2023 | 1.16B | 66.38M | 6.09% |
| Jan 1, 2022 | 1.09B | 60.99M | 5.93% |
| Dec 31, 2020 | 1.03B | 455.95M | 79.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |